Yanqing Wang
Changzhi Medical College(CN)Nanjing Medical University(CN)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Inflammatory Biomarkers in Disease Prognosis, Bladder and Urothelial Cancer Treatments, MicroRNA in disease regulation
Most-Cited Works
- → Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer(2020)200 cited
- → Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate(2018)67 cited
- → Discovery of extracellular vesicles derived miR-181a-5p in patient's serum as an indicator for bone-metastatic prostate cancer(2020)62 cited
- → Systemic immune‐inflammation index predicts the combined clinical outcome after sequential therapy with abiraterone and docetaxel for metastatic castration‐resistant prostate cancer patients(2017)61 cited
- → Extended Focal Ablation of Localized Prostate Cancer With High-Frequency Irreversible Electroporation(2022)61 cited
- → Deep convolutional neural networks combine Raman spectral signature of serum for prostate cancer bone metastases screening(2020)51 cited
- → Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway(2017)50 cited
- → HOXD13 suppresses prostate cancer metastasis and BMP4‐induced epithelial‐mesenchymal transition by inhibiting SMAD1(2021)49 cited
- → Preoperative prognostic nutritional index is a significant predictor of survival in patients with localized upper tract urothelial carcinoma after radical nephroureterectomy(2017)48 cited
- → Prognostic value of preoperative plasma fibrinogen level and platelet-to-lymphocyte ratio (F-PLR) in patients with localized upper tract urothelial carcinoma(2016)42 cited